{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T14:27:21Z","timestamp":1780756041306,"version":"3.54.1"},"reference-count":19,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,8]]},"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>Enteric-coated mycophenolate sodium is frequently used in renal transplantation. The pharmacokinetic profile of mycophenolic acid (MPA) shows a broad range of time-to-maximum concentration (T<jats:sub>max<\/jats:sub>) that limits the use of a single MPA concentration to calculate the area under the time\u2013concentration curve (AUC). For both research and clinical MPA monitoring, measuring a complete AUC is troublesome to the center and patients.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>We obtained 171 complete MPA-AUC<jats:sub>12h<\/jats:sub> (0, 20, 40, 60, 90, 120, 180, 240, 360, 480, 600, and 720 minutes) from 59 adult (54 \u00b1 16 years) patients (29 men and 43 whites) who have been receiving stable doses of tacrolimus\/enteric-coated mycophenolate sodium and steroids. We used the 59 curves drawn at 31 \u00b1 4 days after transplantation to develop the abbreviated equations, and the remaining 112 curves drawn at 109 \u00b1 59 days were used to validate them. We used 5 other proposed equations to estimate MPA-AUC (eAUC) (4 with enzyme-multiplied immunoassay technique assay and one with high-performance liquid chromatography [HPLC]) and then used these results to compare with our measured AUC, the bias, and the 10% and 30% accuracy. MPA was measured by ultraperformance liquid chromatography coupled to a tandem mass spectrometry, and AUC was calculated by the trapezoidal rule.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>For both MPA-measuring methods, enzyme-multiplied immunoassay technique and ultraperformance liquid chromatography coupled to a tandem mass spectrometry, the Hospital das Cl\u00ednicas da Faculdade de Medicina da Universidade de S\u00e3o Paulo (HCFMUSP) equations, and others that measure MPA up to 6 hours after the dose had an acceptable low bias with more results in the 10%\u201330% range than those using data collected until 4 hours. A highly adequate eAUC is obtained using blood collected at 8 hours.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>This analysis offers blood-sampling alternatives for MPA monitoring depending on the precision needed.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/ftd.0000000000000529","type":"journal-article","created":{"date-parts":[[2018,5,10]],"date-time":"2018-05-10T02:38:02Z","timestamp":1525919882000},"page":"411-416","source":"Crossref","is-referenced-by-count":1,"title":["Development of an Abbreviated Mycophenolic Acid Area Under the Time\u2013Concentration Curve for Renal Transplant Patients Under Enteric-Coated Mycophenolate Sodium: A Comparison With Critical Analysis of Available Equations"],"prefix":"10.1097","volume":"40","author":[{"given":"Elias","family":"David-Neto","sequence":"first","affiliation":[{"name":"Division of Urology, Renal Transplantation Service, Hospital das Cl\u00ednicas, S\u00e3o Paulo University School of Medicine; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Heloisa","family":"Triboni","sequence":"additional","affiliation":[{"name":"Division of Urology, Renal Transplantation Service, Hospital das Cl\u00ednicas, S\u00e3o Paulo University School of Medicine; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernanda","family":"Ramos","sequence":"additional","affiliation":[{"name":"Division of Urology, Renal Transplantation Service, Hospital das Cl\u00ednicas, S\u00e3o Paulo University School of Medicine; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabiana","family":"Agena","sequence":"additional","affiliation":[{"name":"Division of Urology, Renal Transplantation Service, Hospital das Cl\u00ednicas, S\u00e3o Paulo University School of Medicine; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paschoalina","family":"Romano","sequence":"additional","affiliation":[{"name":"Division of Central Laboratory (LIM-03), Hospital das Cl\u00ednicas, S\u00e3o Paulo University School of Medicine, S\u00e3o Paulo, Brazil."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230814","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1093\/ckj\/sfw001","article-title":"Therapeutic drug monitoring of enteric-coated mycophenolate sodium by limited sampling strategies is associated with a high rate of failure","volume":"9","author":"Hougardy","year":"2016","journal-title":"Clin Kidney J."},{"key":"R2-20230814","doi-asserted-by":"crossref","first-page":"76","DOI":"10.12659\/AOT.889691","article-title":"Comparison of the exposure of mycophenolate mofetil and enteric-coated mycophenolate sodium in recipient of kidney-pancreas transplantation","volume":"19","author":"Belliere","year":"2014","journal-title":"Ann Transpl."},{"key":"R3-20230814","doi-asserted-by":"crossref","first-page":"3238","DOI":"10.1016\/S0041-1345(01)02377-6","article-title":"Enteric coating of mycophenolate sodium: a rational approach to limit topical gastrointestinal lesions and extended the therapeutic index of mycophenolate","volume":"33","author":"Bjarnason","year":"2001","journal-title":"Transpl Proc."},{"key":"R4-20230814","doi-asserted-by":"crossref","first-page":"827","DOI":"10.2165\/0003088-200847120-00007","article-title":"Population pharmacokinetics of mycophenolic acid: a comparison between enteric-coated mycophenolate sodium and mycophenolate mofetil in renal transplant recipients","volume":"47","author":"Winter","year":"2008","journal-title":"Clin Pharmacokinet."},{"key":"R5-20230814","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s00406-016-0736-z","article-title":"Clinical response in a risperidone-medicated naturalistic sample: patients characteristics and dose-dependent pharmacokinetic patterns","volume":"267","author":"Paulzen","year":"2017","journal-title":"Eur Arch Psychiatry Clin Neurosci."},{"key":"R6-20230814","doi-asserted-by":"crossref","first-page":"341","DOI":"10.2215\/CJN.07111009","article-title":"Consensus report on therapeutic drug monitoring of mycophenolic acid in solid organ transplantation","volume":"5","author":"Kuypers","year":"2010","journal-title":"Clin J Am Soc Nephrol."},{"key":"R7-20230814","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.1111\/j.1600-6143.2007.01983.x","article-title":"Individualized mycophenolate mofetil dosing based on drug exposure significantly improves patient outcomes after renal transplantation","volume":"7","author":"Le Meur","year":"2007","journal-title":"Am J Transpl."},{"key":"R8-20230814","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1097\/TP.0b013e318186f98a","article-title":"Comparing mycophenolate mofetil regimens for de novo renal transplant recipients: the fixed-dose concentration-controlled trial","volume":"86","author":"Van Gelder","year":"2008","journal-title":"Transplantation."},{"key":"R9-20230814","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1016\/j.transproceed.2005.03.090","article-title":"Therapeutic mycophenolic acid monitoring by means of limited sampling strategy in orthotopic heart transplant patients","volume":"37","author":"Baraldo","year":"2005","journal-title":"Transpl Proc."},{"key":"R10-20230814","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1111\/j.1365-2710.2008.00896.x","article-title":"Estimation of the area under the curve for mycophenolic acid in adult renal transplant patients with concomitant tacrolimus using a limited sampling strategy","volume":"33","author":"Teshima","year":"2008","journal-title":"J Clin Pharm Ther."},{"key":"R11-20230814","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1097\/FTD.0b013e318255cc15","article-title":"Limited-sampling strategy for mycophenolic acid in renal transplant recipients receiving enteric-coated mycophenolate sodium and tacrolimus","volume":"39","author":"Sanchez-Fructuoso","year":"2012","journal-title":"Ther Drug Monit."},{"key":"R12-20230814","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1097\/FTD.0000000000000170","article-title":"Limited sampling strategy for mycophenolic acid in Chinese kidney transplant recipients receiving enteric-coated mycophenolate sodium and tacrolimus during the early posttransplantation phase","volume":"37","author":"Yao","year":"2015","journal-title":"Ther Drug Monit."},{"key":"R13-20230814","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1159\/000351180","article-title":"Evaluation of mycophenolic acid exposure using a limited sampling strategy in renal transplant recipients","volume":"37","author":"Li","year":"2013","journal-title":"Am J Nephrol."},{"key":"R14-20230814","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1111\/j.1365-2125.2009.03612.x","article-title":"Pharmacokinetic and pharmacodynamic analysis of enteric-coated mycophenolate sodium: limited sampling strategies and clinical outcome in renal transplant patients","volume":"69","author":"Sommerer","year":"2010","journal-title":"Br J Clin Pharmacol."},{"key":"R15-20230814","doi-asserted-by":"crossref","first-page":"138","DOI":"10.5414\/CP202583","article-title":"Evaluation of the area under the curve of enteric-coated mycophenolate sodium using a limited sampling strategy in Chinese kidney transplant recipient","volume":"55","author":"Huang","year":"2017","journal-title":"Int J Clin Pharmacol Ther."},{"key":"R16-20230814","first-page":"233","article-title":"Enteric-coated mycophenolate sodium immunosuppression in renal transplant patients: efficacy and dosing","volume":"26","author":"Cooper","year":"2012","journal-title":"Transplantantion."},{"key":"R17-20230814","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1111\/j.1600-6143.2009.02678.x","article-title":"Mycophenolate blood level monitoring: recent progress","volume":"9","author":"Van Gelder","year":"2009","journal-title":"Am J Transpl."},{"key":"R19-20230814","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1097\/00007691-199912000-00010","article-title":"Evaluation of the EMIT mycophenolic acid assay from Dade Behring","volume":"21","author":"Vogl","year":"1999","journal-title":"Ther Drug Monit."},{"key":"R20-20230814","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.chroma.2013.09.062","article-title":"Evaluation between ultrahigh pressure liquid chromatography and high-performance liquid chromatography analytical methods for characterizing natural dyestuffs","volume":"1318","author":"Serrano","year":"2013","journal-title":"J Chromatogr A."}],"container-title":["Therapeutic Drug Monitoring"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00007691-201808000-00006","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,14]],"date-time":"2023-08-14T22:17:09Z","timestamp":1692051429000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00007691-201808000-00006"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":19,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1097\/ftd.0000000000000529","relation":{},"ISSN":["0163-4356"],"issn-type":[{"value":"0163-4356","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8]]}}}